SEED Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

SEED Biosciences General Information

Description

Developer of single-cell dispensing technology designed for precision and efficiency in cell biology research. The company's technology provides secure handling, high cloning efficiency, traceable proof of monoclonality, and disposable tips to prevent cross-contamination, enabling researchers in life sciences to streamline workflows, meet stringent regulatory standards, and enhance experimental accuracy across applications like monoclonal antibody screening and CRISPR-mediated gene editing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building Serine, 3rd Floor
  • Route de la Corniche 6
  • 1066 Epalinges
  • Switzerland
+41 021
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Drug Discovery
Corporate Office
  • Building Serine, 3rd Floor
  • Route de la Corniche 6
  • 1066 Epalinges
  • Switzerland
+41 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SEED Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
7. Debt - General 15-Dec-2021 Completed Generating Revenue
6. Early Stage VC (Series A) 24-Sep-2020 Completed Generating Revenue
5. Accelerator/Incubator 06-Feb-2020 Completed Startup
4. Accelerator/Incubator 30-Jan-2020 Completed Startup
3. Seed Round 10-Oct-2018 Completed Startup
2. Grant 31-May-2018 $20.1K Completed Startup
1. Grant 30-Jan-2018 $10.4K Completed Startup
To view SEED Biosciences’s complete valuation and funding history, request access »

SEED Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view SEED Biosciences’s complete cap table history, request access »

SEED Biosciences Patents

SEED Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4508413-A1 System and method for impedance-based analysis of biological entities Pending 12-Apr-2022
US-20250251332-A1 System and method for impedance-based analysis of biological entities Pending 12-Apr-2022
WO-2023199234-A1 System and method for impedance-based analysis of biological entities Inactive 12-Apr-2022 G01N15/12

SEED Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SEED Biosciences Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biopole (Epalinges) Accelerator/Incubator
Ecole Polytechnique Federale de Lausanne University Minority
Merck Innovation Center Accelerator/Incubator Minority
To view SEED Biosciences’s complete investors history, request access »

SEED Biosciences FAQs

  • When was SEED Biosciences founded?

    SEED Biosciences was founded in 2018.

  • Where is SEED Biosciences headquartered?

    SEED Biosciences is headquartered in Epalinges, Switzerland.

  • What is the size of SEED Biosciences?

    SEED Biosciences has 20 total employees.

  • What industry is SEED Biosciences in?

    SEED Biosciences’s primary industry is Biotechnology.

  • Is SEED Biosciences a private or public company?

    SEED Biosciences is a Private company.

  • What is SEED Biosciences’s current revenue?

    The current revenue for SEED Biosciences is .

  • How much funding has SEED Biosciences raised over time?

    SEED Biosciences has raised $1.78M.

  • Who are SEED Biosciences’s investors?

    Biopole (Epalinges), Ecole Polytechnique Federale de Lausanne, and Merck Innovation Center have invested in SEED Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process